Rauch S, Costacurta F, Schoppe H, Peng JY, et al. Highly specific SARS-CoV-2 main protease (M(pro)) mutations against the clinical antiviral ensitrelvir selected in a safe, VSV-based system. Antiviral Res 2024 Jul 23:105969. doi: 10.1016/j.antiviral.2024.105969.
PMID: 39053514